Henan Lingrui Pharmaceutical Co., Ltd. operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Henan Lingrui Pharmaceutical Co., Ltd. with three other
companies in this sector in China:
Porton Fine Chemicals Ltd
sales of 1.02 billion Chinese Renmimbi [US$151.47 million]
of which 85%
was Pharmaceutical R&D Production Service Cu),
Huaren Pharmaceutical Co Ltd
(1.11 billion Chinese Renmimbi [US$164.06 million]
of which 82%
was Medicine Industry), and
Tibet Cheezheng Tibetan Medicine Co Ltd
(994.61 million Chinese Renmimbi [US$147.55 million]
of which 100%
was Pharmaceutical industry).
Henan Lingrui Pharmaceutical Co., Ltd. reported sales of 1.07 billion Chinese Renmimbi (US$158.70 million)
December of 2015.
increase of 29.5%
versus 2014, when the company's sales were 825.79 million Chinese Renmimbi.
Sales at Henan Lingrui Pharmaceutical Co., Ltd. have increased during each of the previous five years
(and since 2010, sales have increased a total of 181%).
Sales of Healthcare saw an increase
30.0% in 2015, from
813.49 million Chinese Renmimbi to 1.06 billion Chinese Renmimbi.